Why the study?
Does obesity increase the risk of cardiovascular thrombotic events in patients undergoing PCI with drug-eluting stents?
Population
4,972 patients undergoing percutaneous coronary intervention with drug-eluting stents between January 2004…
Comparison
Obesity (BMI ≥30 kg/m²) vs Normal weight and overweight
Design
Cohort
Follow-up
median 26 months (interquartile range 20-33)
Authors
Loading...
Obesity may warrant closer post-PCI surveillance; leaves open whether weight loss modifies stent thrombosis risk.
Does obesity increase the risk of cardiovascular thrombotic events in patients undergoing PCI with drug-eluting stents?
Obese patients undergoing PCI with drug-eluting stents have a significantly higher risk of long-term cardiovascular thrombotic events and stent thrombosis compared to normal-weight patients.
Wang et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: